GlassScriptPhysician profile
Sung W Choi
NPI 1013917046
$2,886.99
in general payments reported to CMS, 2019-2025
22 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,671 · 2020: $503 · 2021: $63.86 · 2022: $147 · 2024: $201 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $487.82 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $367.93 | 2019-2020 | |
| Amgen INC. | $278.32 | 2019-2020 | |
| Abiomed | $222.93 | 2019-2022 | |
| Medtronic Vascular, INC. | $198.33 | 2019 | |
| Heartflow, INC. | $192.15 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.03 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $124.99 | 2019 | |
| Astellas Pharma US INC | $107.50 | 2019-2020 | |
| Edwards Lifesciences Corporation | $102.29 | 2024 | |
| Terumo Medical Corporation | $98.81 | 2024 | Glidesheath Slender |
| Cathworks, INC. | $94.87 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $84.17 | 2019 | |
| Boston Scientific Corporation | $74.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.97 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $59.19 | 2019-2021 | |
| Cardiovascular Systems INC. | $49.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $43.10 | 2019 | |
| Irhythm Technologies, INC. | $31.07 | 2019-2020 | |
| Abbott Laboratories | $24.50 | 2025 | Portico |
| Chiesi USA, INC. | $16.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.